METTL3 and hepatocellular carcinoma: For instance, METTL3 silencing can be synergistically implemented with the glycolysis inhibitor 2-deoxyglucose (2-DG) to block HCC growth [298] and combined inhibition of METTL3 and autophagy increases the sensitivity of spermatocytoma to cisplatin [299].